Packaging Machinery Market to Register Stable Expansion During 2021 – 2028: Grand View Research Inc.

 Packaging Machinery Market Growth & Trends

The global packaging machinery market size is expected to reach USD 59.24 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.1% from 2021 to 2028. The rising demand for packaged food and beverages, coupled with the growing pharmaceutical and personal care industries, is expected to drive the demand for packaging machinery over the forecast period.

The growing popularity of single-serve bag sizes and smaller portions has increased the demand for high-speed and efficient packaging machines. Moreover, with the consumer-driven demand for a wide range of products in different packaging sizes and shapes, there is an increasing demand for flexible packaging machines that can adapt to different products and pack styles.

Consumers and retailers are increasingly demanding sustainable packaging styles resulting in the machine manufacturers requiring to work closely with material suppliers to test new materials and make necessary modifications to the machine. Moreover, with the rapid developments in retail packaging formats, the demand for faster and more flexible machines has increased.

The market is expected to witness growth in the years to come on account of the rising demand for personal care and medical products, such as hand sanitizers, soaps, face masks, and gloves, despite the supply chain disruptions caused due to the COVID-19 pandemic. In addition, lockdowns and movement restrictions have further increased the demand for packaged food.

Request a free sample copy or view report summary: Packaging Machinery Market Report

Packaging Machinery Market Report Highlights

• By machine type, the form-fill-seal segment is anticipated to expand at the fastest CAGR of 5.2% over the forecast period on account of the increasing popularity of flexible packaging, coupled with the rising demand for single-serve and small portion packs
• The food end-use segment accounted for the largest share of over 35.0% in 2020 owing to the increasing demand for packaged food products attributed to the changing lifestyles, increasing disposable income, and the growing middle-class population
• The North American market is likely to expand at a CAGR of 3.2% from 2021 to 2028 due to the increasing demand for highly automated and integrated machines, coupled with the favorable packaging and labeling regulations in the region
• The market in China is anticipated to expand at a CAGR of 5.3% over the forecast period owing to the growing focus on improving productivity, coupled with the favorable government policies focusing on technology and machinery upgrades
• In June 2020, Hugo Beck Maschinen bau GmbH & Co. KG. launched two machines, namely PB 800 E-Com and flexo 700 E-Com, which are explicitly designed to cater to the demand for e-commerce packaging

Access Press Release@ https://www.grandviewresearch.com/press-release/global-packaging-machine-market

Packaging Machinery Market Segmentation

Grand View Research has segmented the global packaging machinery market on the basis of machine type, end-use, and region:

Packaging Machinery Machine Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Filling
• Labeling
• Form-Fill-Seal
• Cartoning
• Wrapping
• Palletizing
• Bottling Line
• Others

Packaging Machinery End-use Outlook (Revenue, USD Billion, 2017 - 2028)

• Beverages
• Food
• Chemicals
• Personal Care
• Pharmaceuticals
• Others

Packaging Machinery Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • Russia
  • Spain
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia
  • UAE

List of Key Players of Packaging Machinery Market

• KHS Group
• SIG Combibloc Group Ltd.
• Tetra Laval International S.A.
• Krones AG
• M.A. Industria Macchine Automatiche S.p.A.
• Syntegon Technology GmbH
• ProMach
• GEA Group Aktiengesellschaft
• Sacmi
• Bradman Lake Ltd.
• ROVEMA GmbH
• Douglas Machine Inc.
• Coesia S.p.A
• Maillis Group
• Duravant

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nutraceuticals Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 Nutraceuticals Market Growth & Trends

The global nutraceutical market size is projected to reach USD 826,426.3 million by 2028, expanding at a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Rising awareness regarding calorie reduction and weight loss in countries, including U.S., China, and India, is expected to promote the application of nutraceuticals, which, in turn, will have a substantial impact on the industry growth.

Nutraceuticals are products that provide health advantages and additional nutrition to the human body. It comprises fortified nutrients, such as taurine, CoQ10, omega-3, calcium, zinc, and antioxidants, that enhance the complete health of consumers. These nutrients further help in averting medical conditions, such as hypertension, diabetes, heart diseases, and allergies. Demand for nutraceuticals is increasing at the global level as it improve the digestive and immune systems and enhances the cognitive behavior of consumers.

Growing trend among consumers to alter dietary habits is likely to boost the demand for nutraceuticals. The consumer belief that improper diet results in an increase in costs on pharmaceuticals are anticipated to boost the demand for nutraceuticals. This would also help the government as it would result in lesser expenditure on healthcare and low social security costs.

Rise in disposable income, increasing consumer awareness concerning health issues, and rapid urbanization are likely to boost the nutraceutical market growth over the forecast years. Positive outlook towards medical nutrition owing to increasing weight management programs, along with cardiovascular diseases, is anticipated to propel the demand for nutraceuticals.

The rise and evolution of wellness-focused diets, such as keto and paleo, are driving food producers to cater their products in this direction. Functional food products, such as probiotics and omega-3, are highly used in yogurt and fish oils in order to reduce the risk of cardiovascular diseases and develop the quality of intestinal microflora, which is further projected to fuel the market growth of the nutraceutical products over the coming years.

Request a free sample copy or view report summary: Nutraceuticals Market Report

Nutraceuticals Market Report Highlights

• Based on functional food product, prebiotics and probiotics are projected to expand at a CAGR of 10.1% over the forecast period owing to increasing usage of probiotics as a primary ingredient among the majority of food manufacturing companies to provide better nourishment and reduce health problems caused by harmful bacteria
• Vitamins and minerals together accounted for over 40.71% share in 2019 owing to increasing consumer interest in the relationship between diet and health, which, in turn, has increased demand for these products
• In terms of dietary supplement product, vitamins emerged as the largest segment in 2019 and is expected to expand at a CAGR of 5.8% in the coming years
• In terms of product, functional food accounted for the largest share in 2019 and generated revenue of USD 187.51 billion. Rising healthcare costs, coupled with growing geriatric population across the world, are anticipated to drive the functional food segment over the forecast period
• Asia Pacific is expected to witness the fastest growth over the forecast period. Expansion of the retail chain in countries, such as India, Japan, and China, has increased the consumption of dietary supplements and functional foods in this region
• The nutraceuticals industry represents a highly competitive landscape. Key players dominate the nutraceutical market space and have been focusing on various strategic initiatives, including mergers & acquisitions, product innovation, and portfolio expansion
• Key market participants include Cargill, Incorporated, Archer Daniels Midland Company, DuPont, Nestle S.A, Danone, General Mills, Innophos, WR Grace, and Amway Corporation.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nutraceuticals-market

Nutraceuticals Market Segmentation

Grand View Research has segmented the global nutraceutical market on the basis of product and region.

Nutraceuticals Product Outlook (Revenue, USD Million, 2017 - 2028)

• Dietary Supplements
• Functional Food
• Functional Beverages

Nutraceuticals Dietary Supplements Product Outlook (Revenue, USD Million, 2017 - 2028)

• Vitamins
• Botanicals
• Minerals
• Proteins & Amino Acids
• Fibers & Specialty Carbohydrates
• Omega Fatty Acids
• Others

Nutraceuticals Functional Food Outlook (Revenue, USD Million, 2017 - 2028)

• Carotenoids
• Dietary Fibers
• Fatty Acids
• Minerals
• Prebiotics & Probiotics
• Vitamins
• Others

Nutraceuticals Functional Beverages Outlook (Revenue, USD Million, 2017 - 2028)

• Energy Drinks
• Sports Drinks
• Functional Juices
• Others
• Infants

Nutraceuticals Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa

List of Key Players of Nutraceuticals Market

• Cargill, Inc.
• Archer Daniels Midland Company
• DuPont
• Nestle S.A.
• Danone
• Royal DSM N.V.
• General Mills
• Innophos
• WR Grace
• Amway Corp.
• AOR Canada
• Arkopharma Laboratories S.A.
• Bactolac Pharmaceuticals, Inc.
• I.D Parry Ltd.
• Valensa International
• Matsun Nutrition
• Mead Johnson Nutrition Company
• Natrol Inc.
• The Hain Celestial Group, Inc.
• Herbalife Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Bio-based Polyurethane Market to Reflect Robust Expansion During 2021-2028: Grand View Research Inc.

 Bio-based Polyurethane Market Growth & Trends

The global bio-based polyurethane market size is expected to reach USD 52.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 5.9% from 2021 to 2028. Increasing product demand from the automotive industry for the manufacturing of seat cushions, seat backs, armrests, head restraints, and others is anticipated to boost the bio-based PU market growth. In automotive applications, the use of natural fiber-reinforced plastics and plant-based polymer resins helps reduce CO2 emissions and the weight of vehicles, which, in turn, helps improve fuel economy. Thus, increasing government concerns to reduce CO2 emissions across the globe are anticipated to fuel the product demand in automotive applications during the forecasted years.

Expanding application scope in the packaging, building & construction, electrical & electronics, automotive, and consumer goods industries is also anticipated to offer growth opportunities to the key players. For instance, in September 2020, Covestro AG announced its partnership with Shandong INOV New Materials Co., Ltd. to complete the laying of the walkway using CO2-based polyolCardyon. This is the first time that innovative CO2-based materials have been used in China to produce sports floorings. Companies, such as Ford Motor Company, ZMP Inc., La-Z-Boy Inc., and Airysole Footwear Pvt. Ltd., are some of the potential customers in the market.

Increasing concerns regarding toxic issues pertaining to petrochemicals along with depleting crude oil reserves have been driving the development of bio-based polymers like bio-based polyurethane (PU). Regulations imposed by most governments restricting the consumption of petroleum-based plastics in certain applications like medical devices are expected to further incentivize the production of bio-based polyurethane during the forecast period.

Request a free sample copy or view report summary: Bio-based Polyurethane Market Report

Bio-based Polyurethane Market Report Highlights

• In terms of revenue, the flexible foam segment accounted for the highest revenue share in 2020 and is expected to retain the dominance over the forecast period
• Bio-based PU foams witnessed a rise in demand as an efficient insulation material, leading to higher energy savings, owing to the rising need for green buildings
• These foams are widely used in spray form for sealing holes, cracks, joints, and boding other building materials, ultimately reducing the amount of conditioning or heat required inside the building
• Various strategic initiatives were recorded over the past few years to boost the growth of the market
• For instance, in September 2020, Covestro AG teamed up with FoamPartner, a Swiss company, to develop foams that are partially based on CO2
• Carbon dioxideis used as a raw material to produce polyol instead of fossil raw materials, such as crude oil
• CO2 polyol available under the Cardyon brand name is used as a raw material by FoamPartner to produce polyurethane foams for various parts used in the vehicle interior
• Asia Pacific was the largest regional market in 2020 owing to the presence of a well-established manufacturing base for electrical & electronics in China, Japan, and South Korea

Access Press Release@ https://www.grandviewresearch.com/press-release/global-bio-based-polyurethane-industry

Bio-based Polyurethane Market Segmentation

Grand View Research has segmented the global bio-based polyurethane market based on product, end-use, and region:

Bio-based PU Product Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

• Rigid Foam
• Flexible Foam
• Coatings, Adhesives, & Sealants
• Others

Bio-based PU End-use Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

• Automotive
• Building & Construction
• Consumer Goods
• Electrical & Electronics
• Packaging
• Others

Bio-based PU Regional Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players of Bio-based Polyurethane Market

• BASF SE
• MCNS
• RAMPF Holding GmbH & Co. KG
• Covestro AG
• Cargill, Inc.
• Huntsman International LLC
• MCPU Polymer Engineering LLC
• WeylChem International GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ultraviolet Disinfection Equipment Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

 Ultraviolet Disinfection Equipment Market Growth & Trends

The global ultraviolet disinfection equipment market size is expected to reach USD 8.39 billion by 2028, registering a CAGR of 12.1% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of coronavirus coupled with the increasing R&D spending is expected to boost the product demand over the forecast period.

The COVID-19 pandemic has increased the pressure on the healthcare systems of numerous countries. Growth in the COVID-19 cases has resulted in a wide range of hospitals incorporating ultraviolet (UV) systems to disinfect the high-risk indoor setting, which, in turn, is expected to increase the product demand over the coming years.

UV has been a choice of disinfectant to ensure bacteria-free water in industries, such as food & beverage and pharmaceutical. However, the rising demand for disinfection technologies owing to the increasing industrial liquid waste is expected to create opportunities for UV disinfection systems in the wastewater treatment industry over the forecast period.

Rising awareness about the product’s ability to provide protection against cryptosporidium outbreaks is anticipated to support market growth. Furthermore, these systems have a low environmental footprint and consume less energy, which will drive UV disinfection equipment market growth.

Request a free sample copy or view report summary: Ultraviolet Disinfection Equipment Market Report

Ultraviolet Disinfection Equipment Market Report Highlights

• Mercury-based UV lamps are anticipated to grow at the fastest CAGR of 13.2% from 2020 to 2028 on account of their increasing adoption in water & wastewater treatment plants
• The equipment demand in the healthcare facilities for air treatment accounted for 39.2% of the overall revenue owing to the high focus to provide innovative medical-grade air purifiers, such as UV systems
• The residential end-use segment is estimated to grow at the second-fastest CAGR over the forecast period on account of the increasing consumer awareness regarding air pollution coupled with the rising prevalence of airborne diseases
• Germany accounted for the largest revenue share of 20.4% of the Europe market in 2020 due to the increasing demand for technologically advanced and sustainable air purification technology along with the rising prevalence of COVID-19 in the country
• Key players in the market are focusing on various strategies, including acquisitions, regional expansions, and product innovations, to achieve competitive advantage and, thereby, develop a strong foothold in the industry

Access Press Release@ https://www.grandviewresearch.com/press-release/global-uv-disinfection-equipment-market

Ultraviolet Disinfection Equipment Market Segmentation

Grand View Research has segmented the global ultraviolet disinfection equipment market on the basis of component type, application, end-use, and region:

UV Disinfection Equipment Component Type Outlook (Revenue, USD Million, 2017 - 2028)

• UV Lamps
  • Mercury
    • Low-pressure
    • Medium-pressure
    • Amalgam
  • Xenon/LED
• Ballasts/Controller Units
• Quartz Sleeves
• Reactor Chambers
• Others

UV Disinfection Equipment Application Outlook (Revenue, USD Million, 2017 - 2028)

• Water & Wastewater Treatment
• Air Treatment
  • Residential
  • Healthcare Facilities
  • Retail Shops
  • Offices
  • Hospitality
  • Schools & Educational Institutions
  • Industrial
  • Others
• Others

UV Disinfection Equipment End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Municipal
• Residential
• Commercial
• Industrial

UV Disinfection Equipment Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE

List of Key Players of Ultraviolet Disinfection Equipment Market

• Xylem
• Trojan Technologies
• Halma PLC
• Calgon Carbon Corp.
• Atlantic Ultraviolet Corp.
• Evoqua Water Technologies LLC
• Advanced UV, Inc.
• American Ultraviolet
• Atlantium Technologies LTD.
• Hönle AG
• Lumalier Corp.
• Xenex
• ENAQUA
• I.T.A. Srl
• Hitech Ultraviolet Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Enterprise Governance, Risk & Compliance | Increasing Adoption Of Big Data And IoT In GRC Solutions

 

Know more- https://www.grandviewresearch.com/industry-analysis/enterprise-governance-risk-compliance-egrc-market

The increasingly complex regulatory, compliance, and risk management environment in businesses has paved the way for GRC solutions. Enterprise governance, risk & compliance (EGRC) enables risk and compliance management teams to analyze and share data for a 360-degree view of the organization’s risk landscape, in turn enabling executives and boards to formulate informed business strategies. The wide implementation of EGRC software applications across enterprises to prevent monetary and reputational risks due to non-compliance is providing an impetus for market growth.

North America Food Packaging Market is Growing at Significant Rate, 2028: Grand View Research Inc.

 North America Food Packaging Market Growth & Trends

The North America Food Packaging market size is expected to reach USD 135.52 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.9% from 2020 to 2028. The market is anticipated to be driven by a surge in demand for food delivery services, coupled with the rapid growth in single-serve and portable food packs.

Plastic packaging products are affordable and offer robust barrier properties, which contribute to their widespread penetration in the food and beverage industry. With the increasing government intervention in plastic product manufacturing, producers operating in the plastic food packaging market are making efforts to offer products using eco-friendly and sustainable raw materials.

The hectic work schedules of consumers and the increased demand for convenient food options drive the market for packaged food items in North America. Moreover, the flourishing e-commerce industry in different countries of the region such as Canada and Mexico is fueling the sales of packed food items across the region.

The extensive presence of large-sized packaged food companies with a robust penetration of distribution channels, such as supermarket and hypermarket chains, in North America is expected to contribute to the growth of food packaging types, such as trays, containers, pouches, and bags, during the forecast period.

Request a free sample copy or view report summary: North America Food Packaging Market Report

North America Food Packaging Market Report Highlights

• By material, the paper and paper-based food packaging material segment is expected to expand at the highest CAGR of 5.5% during the forecast period owing to the increasing demand for biodegradable and more sustainable packaging solutions
• By type, under the flexible segment, the pouches segment is expected to witness the highest growth from 2020 to 2028 as they occupy lesser space during transportation, consume less plastic material, and present a better sustainability profile in comparison to their rigid counterparts
• The rigid type segment accounted for the largest revenue share in 2020. The high adoption of rigid packaging products, such as bottles and jars, trays and containers, and caps and closures, owing to their durability and property of offering high protection to food and beverage products is contributing to the segment growth
• Based on application, the packaged food segment accounted for the largest revenue share of over 70.0% in 2020. The high demand for packaged foods owing to the change in consumer lifestyle has driven the segment in recent years and the trend is expected to continue over the forecast period
• The market is steadily moving toward sustainable packaging owing to the rising stringent regulations on the use of excessive plastic packaging, coupled with the growing awareness regarding sustainability among consumers

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-food-packaging-market-analysis

North America Food Packaging Market Segmentation

Grand View Research has segmented the North America food packaging market on the basis of type, material, application, and country:

North America Food Packaging Type Outlook (Revenue, USD Million, 2017 - 2028)

• Rigid
  • Bottles & Jars
  • Cans
  • Trays & Containers
  • Caps & Closures
    • Dispensing Caps
    • Screw Closures
    • Crown Closures
    • Aerosol Closures
    • Others
  • Others
• Flexible
  • Wraps & Films
  • Bags
  • Pouches
  • Others

North America Food Packaging Material Outlook (Revenue, USD Million, 2017 - 2028)

• Paper & Paper-based
• Plastic
  • PE
  • PP
  • PET
  • Others
• Metal
• Glass
• Others

North America Food Packaging Application Outlook (Revenue, USD Million, 2017 - 2028)

• Packaged Food
• Food Service Industry
• Household

North America Food Packaging Country Outlook (Revenue, USD Million, 2017 - 2028)

• US.
• Canada
• Mexico

List of Key Players of North America Food Packaging Market

• Amcor plc
• Sealed Air
• Sonoco Products Company
• Berry Global, Inc.
• WestRock Company
• Mondi
• Genpak LLC
• Pactiv LLC
• Chantler Packages
• WINPAK LTD.
• Alpha Packaging
• BE Packaging
• Cheer Pack North America
• Evanesce Packaging Solutions Inc.
• Pacmoore Products Inc.
• Innovative Fiber
• Emmerson Packaging
• PakTech
• Tradepak
• ProAmpac

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-Vascular Endothelial Growth Factor Therapeutics Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

 Anti-Vascular Endothelial Growth Factor Therapeutics Market Growth & Trends

The global anti-vascular endothelial growth factor therapeutics market size is expected to reach USD 12.82 billion by 2028, registering a CAGR of 0.5% over the forecast period, according to a new report by Grand View Research, Inc. Increased funding for R&D of anti-VEGF therapeutics to boost the development of new drugs is expected to accelerate market growth. Moreover, the introduction of novel innovative products coupled with the increasing geriatric population that is susceptible to develop ophthalmic diseases is expected to propel the market growth over the forecast period.

According to the United Nations Department of Economic and Social Affairs data, the global elderly population (aged 60 years and above) was around 703 million in 2019. The share of the population aged 65 years and above was 6%, which increased to 9% in 2019. The aging population, based on countries, was around 68.7 million in Africa, 549.2 million in Asia, 183 million in Europe, 78.4 million in North America, and more than 76 million in Latin America & other regions in 2017. Hence, the increasing geriatric population is anticipated to drive the market.

The lack of reimbursement policies in developing regions is creating an opportunity for cost-effective novel molecules. In addition, ophthalmologists switching to more effective newly launched drugs has compelled companies to invest in R&D to maintain their industry position. The interest of investigators on biosimilar of existing drugs is a major trend in the pipeline of anti-VEGF therapeutics.

Moreover, companies are developing various formulations and drug delivery systems that may increase the adoption of these therapies. For instance, F. Hoffmann La Roche Ltd. is developing the port delivery system-RG6321 (Ranibizumab)-which is currently undergoing a phase III clinical trial. It is an eye implant that is refillable and continuously delivers a customized formulation of ranibizumab over a period of months.

Loss of patent protection is likely to have a negative impact on the market growth and has led big pharma companies to consider new revenue streams. However, this is creating an emerging market for biosimilar drug producers in the space. This rising competition is anticipated to impede market growth. However, the launch of novel products with a competitive advantage is anticipated to lower the impact of the restraint during the forecast period.

Request a free sample copy or view report summary: Anti-Vascular Endothelial Growth Factor Therapeutics Market Report

Anti-Vascular Endothelial Growth Factor Therapeutics Market Report Highlights

• In 2020, Age-related Macular Degeneration (AMD) accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period
• Diabetic retinopathy is anticipated to witness significant growth over the forecast period due to increasing cases of diabetes across the globe
• The Beovu segment is expected to grow at the fastest CAGR over the forecast period due to the geographic expansion and patent exclusivity
• Product expansions in various geographic regions are expected to increase sales and customer base
• North America was the largest regional market in 2020 due to the high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure
• Asia Pacific is anticipated to witness the fastest CAGR over the forecast period due to a rise in the penetration of anti-VEGF products, rising disposable income, and growing consumer awareness

Access Press Release@ https://www.grandviewresearch.com/press-release/global-anti-vascular-endothelial-growth-factor-therapeutics-market

Anti-Vascular Endothelial Growth Factor Therapeutics Market Segmentation

Grand View Research has segmented the global Anti-Vascular Endothelial Growth Factor Therapeutics Market on the basis of products, disease, and region:

Anti-VEGF Therapeutics Product Outlook (Revenue, USD Million, 2017 - 2028)

• Eylea
• Lucentis
• Beovu

Anti-VEGF Therapeutics Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Macular Edema
• Diabetic Retinopathy
• Retinal Vein Occlusion
• Age-related Macular Degeneration

Anti-VEGF Therapeutics Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Anti-Vascular Endothelial Growth Factor (VEGF) Therapeutics Market

• Hoffmann-La Roche Ltd.
• Biogen
• Pfizer, Inc.
• CoherusBioSciences
• Amgen, Inc.
• Bausch Health Companies, Inc.
• Viatris, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Insufflation Devices Market to Reach Around USD 3.76 Billion by 2028: Grand View Research Inc.

 Insufflation Devices Market Growth & Trends

The global insufflation devices market size is expected to reach USD 3.76 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.3% from 2021 to 2028. Increasing adoption of minimally invasive surgeries, rapidly aging population, and rising number of laparoscopic procedures are among the major factors driving this market’s growth.

The COVID-19 outbreakhas caused the global implementation of strict measures to curbthe spread, which has led to the cancelation/delayof elective surgeries, including many laparoscopic procedures world wide. A large number of medical device manufacturing companies and global suppliers have been adversely affected during this time. However, with the abundance of deferred medical procedures in the pipeline, the market is likely to rebound and grow significantly over the forecast period.

Obesity or overweight are major health concerns that lead to a number of associated diseases or complications, such as diabetes and cardiovascular diseases. As per the WHO, in 2016, over 1.9 billion adults were overweight, out of which around 650 million people were obese and around 2.8 million people die each year as a result of being overweight/obese. Such instances are expected to increase the demand for bariatric procedures and other related surgeries, thereby propelling the market growth over the forecast period.

Moreover, growing patient preference for minimally invasive surgeries owing to the reduced risk and trauma associated with these procedures is expected to strengthen the growth of this market. Additionally, minimally invasive laparoscopic surgeries are increasingly being covered by health insurance providers in selected countries. For instance, for laparoscopic surgical operations, Medicare will cover up to 75% of the fee as listed in the Medicare Benefits Schedule. These factors have led to an increased preference for minimally invasive surgeries among patients.

Request a free sample copy or view report summary: Insufflation Devices Market Report

Insufflation Devices Market Report Highlights

• Based on application, the laparoscopic surgery segment dominated the market with a share of more than 35.0% in 2020
• On the basis of end use, the hospitals segment dominated the market with a share of more than 60.0% in 2020
• North America dominated the market with a revenue share of over 35.0% in 2020 owing to the increasing number of laparoscopic procedures and technological advancements
• In Asia Pacific, the market is anticipated to witness remarkable growth over the forecast period due to the presence of a large patient base suffering from chronic disorders and government initiatives for minimizing risks during the treatment

Access Press Release@ https://www.grandviewresearch.com/press-release/global-insufflation-devices-market

Insufflation Devices Market Segmentation

Grand View Research has segmented the global insufflation devices market on the basis of application, end use, and region:

Insufflation Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Laparoscopic Surgery
• Bariatric Surgery
• Cardiac Surgery
• Others

Insufflation Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Insufflation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Insufflation Devices Market

• Fujifilm
• Medtronic
• Stryker
• BD
• Olympus
• Braun Melsungen
• Smith & Nephew
• Karl Storz
• Steris
• CONMED
• Richard Wolf

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Extracorporeal CO2 Removal Devices Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 Extracorporeal CO2 Removal Devices Market Growth & Trends

The global extracorporeal CO2 removal devices market size is estimated to reach USD 118.64 million by 2028, registering a CAGR of 5.27% over the forecast period, according to a new report by Grand View Research, Inc. Technological improvements have changed extracorporeal techniques for CO2 removal in a promising manner to avoid respiratory failure, worsening respiratory acidosis, and to possibly shorten or prevent the duration of invasive mechanical ventilation in patients with exacerbation of asthma and Chronic Obstructive Pulmonary Disease (COPD).

Extracorporeal CO2 removal devices are considered to be an efficient therapy for patients suffering from hypercapnia respiratory failure and may allow clinicians as well as healthcare professionals to improve lung-protective ventilation. These devices can remove adequate CO2 to allow a 50% reduction in alveolar minute ventilation resulting in a substantial reduction in PaCO2. Hence, various advantages associated with these devices are expected to augment the overall market growth.

Extracorporeal CO2 removal devices are effective, safe, and feasible. The usage of these tools in ventilation support has been suggested in clinical situations where they may be useful, including exacerbation of COPD and Acute Respiratory Distress Syndrome (ARDS). The increasing prevalence of COPD across the globe is predicted to accelerate market growth. According to the British Lung Association, around 1.2 million people are diagnosed with COPD in the U.K.

Several manufacturers in the market are focusing on developing technologically advanced and innovative devices to strengthen their industry position. For instance, in November 2015, Alung Technologies received an Expedited Access Pathway (EAP) from the FDA for its Hemolung Respiratory Assist System (RAS). In February 2016, Alung Technologies received USD 12 million financing from existing as well as new investors. This financing helped in the commercialization of Hemolung RAS.

Request a free sample copy or view report summary: Extracorporeal CO2 Removal Devices Market Report

Extracorporeal CO2 Removal Devices Market Report Highlights

• Extracorporeal CO2 machines held the largest revenue share of the global market in 2020 owing to the availability of a wide range of devices
• The COPD application segment accounted for a significant revenue share of the global market in 2020
• The venovenous access segment is expected to account for the largest share by 2028 due to advantages, such as decreased invasiveness, and potential for the early mobilization of patients
• The hospitals end-use segment is estimated to have the fastest CAGR over the forecast period due to the rising number of hospitals in developing economies and increasing competition in healthcare service providers
• North America held the largest market share in 2020 and is anticipated to maintain its dominance over the forecast period
• This is attributable to the growing prevalence of COPD & ARDS and the increasing adoption of advanced devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-extracorporeal-co2-removal-devices-market

Extracorporeal CO2 Removal Devices Market Segmentation

Grand View Research has segmented the global extracorporeal CO2 removal devices market on the basis of product, application, access, end use, and region:

Extracorporeal CO2 Removal Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Extracorporeal CO2 Machines
• Disposables
• Others

Extracorporeal CO2 Removal Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• ARDS
• COPD
• Bridge to Lung Transplant
• Others

Extracorporeal CO2 Removal Devices Access Outlook (Revenue, USD Million, 2016 - 2028)

• Venovenous
• Arteriovenous

Extracorporeal CO2 Removal Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Clinics
• Others

Extracorporeal CO2 Removal Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Extracorporeal CO2 Removal Devices Market

• Medtronic
• Getinge AB
• Xenios AG
• Alung Technologies
• ESTOR SpA
• Medica SpA
• Aferectica Srl

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Shingles Vaccine Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 Shingles Vaccine Market Growth & Trends

The global shingles vaccine market size is expected to reach USD 6.35 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.9% from 2021 to 2028. Increasing incidence of shingles and high awareness regarding shingles in developed countries are contributing to the market growth. According to the CDC, nearly one million cases of shingles are reported each year in the United States. Furthermore, one out of three individuals in the country will develop the disease in their lifetime.

The increasing adoption of vaccines and an increase in the recommendation of vaccination by different government regulatory bodies are expected to drive the market over the forecast period. For instance, in February 2019, the U.K. Joint Committee of Vaccination and Immunization (JCVI) has recommended the use of the recombinant vaccine to prevent shingles in adults aged 60 to 70 years old.

The inclusion of shingles vaccines in national immunization programs of several countries is anticipated to propel the demand for vaccines. For instance, the shingles vaccine is a part of the national immunization program in the U.K. since 2013. The U.K. is the first country in the European region to introduce shingles vaccine in the national immunization program and it costs around USD 130 to the National Health Service (NHS) for each dose of the vaccine. Similarly, other countries such as the U.S., Italy, Australia, and some provinces of Canada and South Korea have also included the vaccine in their immunization program.

Besides, favorable initiatives undertaken by market players and regulatory bodies to increase the awareness among people who are at risk of developing the disease are expected to fuel the market growth over the coming years. For instance, GlaxoSmithKline plc. has launched a campaign to increase vaccination rates among older adults by educating people about the benefits associated with vaccination.

The high efficacy of vaccines is expected to increase the adoption over the forecast period. According to clinical trial results, Shingrix is highly efficient to prevent shingles and postherpetic neuralgia. Two doses of Shingrix are more than 90% effective to prevent the disease in adults aged 50 years and above. Protection stays above 85% for at least the first four years after getting vaccinated.

The availability of vaccines at lower prices, coupled with a high incidence of the disease and high vaccination rate in developed countries, is anticipated to fuel the market growth. The vaccination rate against shingles in the U.K., the U.S., France, Canada, Germany, and South Korea is higher compared to other countries owing to better reimbursement policies and high awareness levels regarding the disease and vaccines. For instance, the U.K. has the highest shingles vaccine uptake with more than 60% vaccination of eligible adults.

Request a free sample copy or view report summary: Shingles Vaccine Market Report

Shingles Vaccine Market Report Highlights

• By product, Shingrix held the largest share in 2020 owing to the high efficacy of the vaccine as compared to others. Shingrix is also expected to grow at a significant CAGR over the forecast period owing to the increasing recommendations by regulatory bodies to prevent shingles
• Based on vaccine type, the recombinant vaccine segment is anticipated to grow at a substantial rate over the forecast period due to the low risk associated with recombinant vaccines
• Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and the rising adoption of vaccination programs in the region
• North America dominated the market in 2020 due to favorable reimbursement policies and rising initiatives to raise awareness among healthcare professionals and patients

Access Press Release@ https://www.grandviewresearch.com/press-release/global-shingles-vaccine-market

Shingles Vaccine Market Segmentation

Grand View Research has segmented the global shingles vaccine market on the basis of product, vaccine type, and region:

Shingles Vaccine Product Outlook (Revenue, USD Million, 2017 - 2028)

• Shingrix
• Zostavax
• SkyZoster

Shingles Vaccine Type Outlook (Revenue, USD Million, 2017 - 2028)

• Recombinant Vaccine
• Live Attenuated Vaccine

Shingles Vaccine Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Shingles Vaccine Market

• GlaxoSmithKline plc.
• SK chemicals
• Green Cross Corp
• CanSinoBIO
• Geneone Life Science
• Vaccitech

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Air Ambulance Services Market Estimated to Experience a Hike in Growth by 2028: Grand View Research Inc.

 Europe Air Ambulance Services Market Growth & Trends

The Europe air ambulance services market size is expected to reach USD 9.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2021 to 2028. The surge in the prevalence of chronic diseases, the rising geriatric population, and increasing healthcare expenditure are key factors for driving the market.

Increasing government funding and initiatives to support air ambulance services in Europe, is stimulating market growth. For instance, recently in April 2021, Norway and the EU had planned to launch an air ambulance with a permanent base in Troms. As part of RescEU, this aircraft will be used to transport patients with severe infectious ailments across the EEA and the entire EU. The aircraft will be integrated into the National Air Ambulance Services of Norway when not used in European assignments. Moreover, Ambulancezorg Nederland (AZN), the national sector institute for ambulance care, provides support to 25 Regional Ambulance Services (RAVs).

COVID-19 pandemic has significantly impacted the market. An upsurge in demand for helicopter emergency medical services from hospitals, health insurance firms, assistance companies, and independent end-users is witnessed amidst COVID-19. Moreover, rising investments in the healthcare domain due to COVID-19 will further boost the market growth. For instance, in September 2020, the Norwegian Air Ambulance Foundation received a 5-bladed Airbus H145 helicopter. The helicopter will help deliver comfort, simplicity, and connectivity and increase the useful load by 150 kg. It has also obtained certification from the European Union Aviation Safety Agency.

Request a free sample copy or view report summary: Europe Air Ambulance Services Market Report

Europe Air Ambulance Services Market Report Highlights

• In terms of type, the rotary-wing segment held the largest share in 2020, owing to the surge in demand for helicopter emergency medical services
• In terms of model, the community-based segment is anticipated to a witness considerable growth rate over the forecast period, due to rising partnerships between private players and community health organizations
• In Germany, the market is expected to witness the fastest growth over the forecast period owing to increasing healthcare expenditure

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-air-ambulance-services-market-analysis

Europe Air Ambulance Services Market Segmentation

Grand View Research has segmented the Europe air ambulance services market on the basis of type, model, and country:

Europe Air Ambulance Services Type Outlook (Revenue, USD Million, 2016 - 2028)

• Rotary Wing
• Fixed Wing

Europe Air Ambulance Services Model Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital-based
• Community-based

Europe Air Ambulance Services Country Outlook (Revenue, USD Million, 2016 - 2028)

• UK.
• Germany
• France
• Italy
• Spain

List of Key Players of Europe Air Ambulance Services Market

• Aero Medical Ambulance Service
• Aero-Dienst GmbH
• Airlec Air Espace
• European Air Ambulance
• REVA, Inc.
• IAS Medical
• Medical Air Service
• Quick Air Jet Charter GmbH
• Babcock Scandinavian Air Ambulance
• Centreline AV Limited
• Airbus S.A.S.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.